Johannes Ermert Selected Research

Johannes Ermert Research Topics

5	Neoplasms (Cancer) 01/2021 - 09/2015
3	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 09/2016
2	Glioma (Gliomas) 05/2020 - 01/2017
2	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 06/2016
1	Mental Disorders (Mental Disorder) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Amyloidosis 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Schizophrenia (Dementia Praecox) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Nervous System Diseases (Neurological Disorders) 12/2016
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2015
1	Sleep Deprivation 02/2007

2	gallium 68 PSMA-11IBA 05/2020 - 01/2017
2	LigandsIBA 05/2020 - 01/2017
2	Protein Isoforms (Isoforms)IBA 09/2016 - 01/2015
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 01/2021
1	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 05/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2020
1	3- (6- methylpyridin- 2- ylethynyl)cyclohex- 2- enone- O- methyloximeIBA 01/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020
1	Coloring Agents (Dyes)IBA 03/2017
1	Evans Blue (Blue, Evans)FDA Link 03/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	AntigensIBA 01/2017
1	Glutamate Receptors (Glutamate Receptor)IBA 12/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 09/2016
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 09/2015
1	AntibodiesIBA 01/2015
1	Basiliximab FDA Link 01/2015
1	glutamate decarboxylase 2IBA 01/2015
1	EnzymesIBA 01/2015
1	Proline (L-Proline)FDA Link 01/2014
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 02/2007
1	8- cyclopenta- 3- (3- fluoropropyl)- 1- propylxanthineIBA 02/2007

2	Therapeutics 01/2021 - 01/2017
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2016
1	Chemoradiotherapy 06/2016
1	Aftercare (After-Treatment) 01/2014